| Hans-Günter Meyer-Thompson | Diamorphin
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.
Oviedo-Joekes E, Dobischok S, Carvajal J, MacDonald S, McDermid C, Klakowicz P, Harrison S, LaJeunesse J, Chow N, Brown M, Gill S, Schechter M.
BMC Health Serv Res. 2023 May 26;23(1):553. doi: 10.1186/s12913-023-09558-6. PMID: 37237256; PMCID: PMC10215060.